Clearance of Extracellular and Cell-Associated Amyloid .BETA. Peptide through Viral Expression of Neprilysin in Primary Neurons.
スポンサーリンク
概要
- 論文の詳細を見る
Amyloid β peptide (Aβ), the pathogenic agent of Alzheimer's disease (AD), is a physiolog-ical metabolite constantly anabolized and catabolized in the brain. We previously dem-onstrated that neprilysin is the major Aβ-degrading enzyme in rico. To investigate whether or not manipulation of neprilysin activity in the brain would be an effective strategy for regulating Aβ levels, we expressed neprilysin in primary cortical neurons using a Sindbis viral vector and examined the effect on Aβ metabolism. The correspond-ing recombinant protein, expressed in the cell bodies and processes, exhibited thior-phan-sensitive endopeptidase activity, whereas a mutant neprilysin with an amino acid substitution in the active site did not show any such activity. Expression of the wild-type neprilysin, but not the mutant, led to significant decreases in both the Aβ40 and 42 levels in the culture media in a dose-dependent manner. Moreover, neprilysin expres-sion also resulted in reducing cell-associated Aβ, which could be more neurotoxic than extracellular Aβ. These results indicate that the manipulation of neprilysin activity in neurons, the major source of Aβ in the brain, would be a relevant strategy for control-ling the All levels and thus the Aβ-associated pathology in brain tissues.
- 社団法人 日本生化学会の論文
著者
-
Saido Takaomi
Laboratory For Proteolytic Neuroscience Riken Brain Science Institute
-
Shirotani Keiro
Laboratory For Proteolytic Neuroscience Riken Brain Science Institute
-
Hama Emi
Laboratory For Proteolytic Neuroscience Riken Brain Science Institute
-
Sekine-aizawa Yoko
Laboratory For Proteolytic Neuroscience Riken Brain Science Institute
-
Aizawa Hiroyuki
Laboratory For Proteolytic Neuroscience Riken Brain Science Institute
-
Masumoto Hajime
Laboratory for Protcolvtic Neuroscience, RIKEN Brain Sclen, Institute
-
Shirotani Keiro
Laboratory for Protcolvtic Neuroscience, RIKEN Brain Sclen, Institute
関連論文
- Overexpression, Purification, and Characterization of Human m-Calpain and Its Active Site Mutant, m-C105S-Calpain, Using a Baculovirus Expression System
- Distribution of Geriatric Disease-Related Genotypes in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA)
- Autolysis of Calpain Large Subunit Inducing Irreversible Dissociation of Stoichiometric Heterodimer of Calpain
- Thimet Oligopeptidase Cleaves the Full-Length Alzheimer Amyloid Precursor Protein at a β-Secretase Cleavage Site in COS Cells^1
- Involvement of Calpain in Osteoclastic Bone Resorption
- Aβ-degrading endopeptidase, neprilysin, in mouse brain : synaptic and axonal localization inversely correlating with Aβ pathology
- Biochemical Identification of the Neutral Endopeptidase Family Membeer Responsible for the Catabolism of Amyloid β Peptide in the Brain^1
- Purification of Nuclear Proteins That Potentially Regulate Transcription of the MUC1 Mucin Gene Induced by a Soluble Factor
- Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease Towards presymptomatic diagnosis, prevention and therapy
- Clearance of Extracellular and Cell-Associated Amyloid β Peptide through Viral Expression of Neprilysin in Primary Neurons
- Animal models of tauopathies
- Thimet Oligopeptidase Cleaves the Full-Length Alzheimer Amyloid Precursor Protein at a .BETA.-Secretase Cleavage Site in COS Cells.
- Clearance of Extracellular and Cell-Associated Amyloid .BETA. Peptide through Viral Expression of Neprilysin in Primary Neurons.
- Purification of Nuclear Proteins That Potentially Regulate Transcription of the MUC1 Mucin Gene Induced by a Soluble Factor.